Artículos

Selección de artículos interesantes por orden cronológico inverso

Si tú conoces algún otro que sea interesante, por favor escribe un comentario sobre el mismo a pie de página.

Si te haces un lío con la bibliografía que tienes recopilada, hay disponible un programa gratuito para su gestión, llamado Biblioseeker, que te ayudará a encontrar rápidamente el artículo que te interese, pudiendo realizar la busqueda en función del año, título del archivo, autores o palabras clave. Da un poco de trabajo al principio, pues tienes que introducir tú mismo los datos de tu bibliografía, pero una vez que te acostumbras resulta muy útil.

*******************************************************************

Antibody-based radiopharmaceuticals for imaging and therapy

J Labelled Comp Radiopharm. 2018 May 17

______________________________________________________

Adverse Reactions to Radiopharmaceuticals: A Survey Based on Clinical Cases Using Criteria of Systematic Review

Ther Innov Regul Sci. 2018 Jan;52(1):109-113

______________________________________________________

 

Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals

Molecules. 2018 Mar 15;23(3

______________________________________________________

A review of paediatric administered radiopharmaceutical activities to determine compliance with prescription guidelines

Nucl Med Commun. 2018 Mar;39(3):205-212

______________________________________________________

Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings

Curr Radiopharm. 2018;11(1):22-33

______________________________________________________

Correction to: Radiopharmaceutical tracers for cardiac imaging

J Nucl Cardiol. 2018 Jan 24. doi: 10.1007/s12350-018-1184-0

______________________________________________________

Radiopharmaceutical tracers for cardiac imaging

J Nucl Cardiol. 2017 Dec 1. doi: 10.1007/s12350-017-1131-5

______________________________________________________

Consensus nomenclature rules for radiopharmaceutical chemistry – Setting the record straight

Nucl Med Biol. 2017 Dec;55:v-xi

______________________________________________________

Technetium-99m radiochemistry for pharmaceutical applications

J Labelled Comp Radiopharm. 2017 Sep;60(11):502-520

______________________________________________________

Evaluation of Radiopharmaceutical Adverse Reaction Reports to the British Nuclear Medicine Society from 2007 to 2016

J Nucl Med. 2017 Dec;58(12):2010-2012

______________________________________________________

 

Radiation dose and risks to fetus from nuclear medicine procedures

Phys Med. 2017 Nov;43:190-198

______________________________________________________

Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons

Drug Dev Ind Pharm. 2017 Sep;43(9):1402-1412

______________________________________________________

Addressing Technetium-99m Shortage

J Am Coll Radiol. 2017 May;14(5):681-683.

______________________________________________________

Radiolabeled peptides: current and new perspectives

Q J Nucl Med Mol Imaging. 2017 Jun;61(2):153-167

______________________________________________________

Dose Estimation in Pediatric Nuclear Medicine

Semin Nucl Med. 2017 Mar; 47(2): 118–125.

______________________________________________________

Radiolabeled inorganic nanoparticles for positron emission tomography imaging of cancer: an overview

Q J Nucl Med Mol Imaging. 2017 Jun;61(2):181-204. doi: 10.23736/S1824-4785.17.02969-7. Epub 2017 Jan 26.

______________________________________________________

Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals

EJNMMI Radiopharm Chem. 2017;1(1):1. doi: 10.1186/s41181-016-0004-6. Epub 2016 Mar 21.

______________________________________________________

Are we “preparing” radiopharmaceuticals?

EJNMMI Radiopharm Chem. 2017;1(1):12. doi: 10.1186/s41181-016-0011-7. Epub 2016 Jul 22.

______________________________________________________

Guidance on validation and qualification of processes and operations involving radiopharmaceuticals.

EJNMMI Radiopharm Chem. 2017;2(1):8. doi: 10.1186/s41181-017-0025-9. Epub 2017 Jun 29.

______________________________________________________

Formulation and purification of therapeutic dose of 90Y-labeled peptides: Some interesting radiochemistry aspects.

Appl Radiat Isot. 2017 Mar;121:1-5. doi: 10.1016/j.apradiso.2016.12.024. Epub 2016 Dec 19.

______________________________________________________

2016 Update of the North American Consensus Guidelines for Pediatric Administered Radiopharmaceutical Activities

J Nucl Med. 2016 Dec;57(12):15N-18N.

______________________________________________________

A simple method for checking the proper functioning of a thin-layer radiochromatograph for radiochemical purity control of radiopharmaceuticals

Appl Radiat Isot. 2016 Dec;118:102-104

______________________________________________________

Effect of blood activity on dosimetric calculations for radiopharmaceuticals

Phys Med Biol. 2016 Nov 7;61(21):7688-7703

______________________________________________________

68 Ga-Ca-phytate particles: A potential lung perfusion agent of synthetic origin prepared in a cold kit format

J Labelled Comp Radiopharm. 2016 Oct;59(12):506-516

______________________________________________________

The concept of minimum detectable activity of radionuclide activity meters and their suitability for routine quality control of radiopharmaceuticals. An experimental study

Appl Radiat Isot. 2016 Jul;113:22-7

______________________________________________________

Fractionated elution using the TEKCIS technetium-99m generator

Nucl Med Commun. 2016 Jun;37(6):664-8

______________________________________________________

Detailed evaluation of different (68)Ge/(68)Ga generators: an attempt toward achieving efficient (68)Ga radiopharmacy

J Labelled Comp Radiopharm. 2016 Mar;59(3):87-94

______________________________________________________

Position paper on requirements for toxicological studies in the specific case of radiopharmaceuticals

EJNMMI Radiopharmacy and Chemistry (2016) 1:1. Published: 21 March 2016

______________________________________________________

Small Molecule Radiopharmaceuticals – A Review of Current Approaches

Front Med (Lausanne). 2016 Feb 23;3:5. doi: 10.3389/fmed.2016.00005. eCollection 2016.

______________________________________________________

Evaluation of a Labelled Bacteriophage with 99mTc as a Potential Agent for Infection Diagnosis

Curr Radiopharm. 2016 Feb 15. [Epub ahead of print]

______________________________________________________

Kit formulation for preparation and biological evaluation of a novel (99m)Tc-oxo complex with metronidazole xanthate for imaging tumor hypoxia

Nucl Med Biol. 2016 Feb;43(2):165-70

______________________________________________________

Residual activities of 99mTc-labelled radiopharmaceuticals in routine nuclear medicine practice

Nucl Med Commun. 2016 Feb 2. [Epub ahead of print]

______________________________________________________

Palliative treatment of metastatic bone pain with radiopharmaceuticals: A perspective beyond Strontium-89 and Samarium-153

Appl Radiat Isot. 2016 Apr;110:87-99.

______________________________________________________

Evaluation of the Efficacy of Targeted Imaging Agents

J Nucl Med. 2016 Jan 14. pii: jnumed.115.169235. [Epub ahead of print]

______________________________________________________

European rules to bring novel radiopharmaceuticals to the clinic

Q J Nucl Med Mol Imaging. 2017 Jan 26

______________________________________________________

Aptamers as radiopharmaceuticals for nuclear imaging and therapy

Nucl Med Biol. 2015 Sep 28. pii: S0969-8051(15)00164-X. doi: 10.1016/j.nucmedbio.2015.09.005. [Epub ahead of print]

______________________________________________________

Improving efficiency management of radiopharmaceutical materials at a nuclear medicine department

BMJ Qual Improv Rep. 2015 Sep 2;4(1).

______________________________________________________

Preparation, characterization and evaluation of (186) Re-idarubicin: a novel agent for diagnosis and treatment of hepatocellular carcinoma

J Labelled Comp Radiopharm. 2016 Feb;59(2):72-7.

______________________________________________________

Study of the radiation effect of 99Mo/99mTc generator on Bacillus subtilis and Bacillus pumilus species.

Appl Radiat Isot. 2016 Jan;107:33-9

______________________________________________________

Advances in Peptide Receptor Radionuclide Therapy

Semin Nucl Med. 2016 Jan;46(1):40-6

______________________________________________________

Molybdenum target specifications for cyclotron production of (99m)Tc based on patient dose estimates

Phys Med Biol. 2016 Jan 21;61(2):542-53

______________________________________________________

Adjusting ACR Appropriateness Criteria for Novel Radiopharmaceuticals

J Am Coll Radiol. 2015 Dec;12(12 Pt A):1242-3. doi: 10.1016/j.jacr.2015.08.021.

______________________________________________________

68 Ga-labeled Ciprofloxacin Conjugates as Radiotracers for Targeting Bacterial Infection

Chem Biol Drug Des. 2015 Dec 9

______________________________________________________

Preparation, biodistribution and scintigraphic evaluation of (99m)Tc-lincomycin

Pak J Pharm Sci. 2015 Nov;28(6):1965-70.

______________________________________________________

Cyclotron production of (43)Sc for PET imaging

EJNMMI Phys. 2015 Dec;2(1):33

______________________________________________________

The strange case of the [13N]NH3: validation of the production process for human use

Nucl Med Commun. 2016 Apr;37(4):412-21.

______________________________________________________

Radionuclidic purity tests in 18F radiopharmaceutIcals production process

Appl Radiat Isot. 2015 Nov 5.

______________________________________________________

Radiolabeled Peptides for Imaging and Therapy: A Radiant Future

J Nucl Med. 2015 Oct 29

______________________________________________________

Studies on batch formulation of a kit for the preparation of the 99mTc-Ubiquicidin (29-41): An infection imaging agent

Appl Radiat Isot. 2015 Sep 11;107:8-12.

______________________________________________________

Radiopharmacology: recent developments in the field of radiopharmaceuticals

Q J Nucl Med Mol Imaging. 2015 Sep;59(3):239-40.

______________________________________________________

Pitfalls and Limitations of SPECT, PET, and Therapeutic Radiopharmaceuticals

Semin Nucl Med. 2015 Sep;45(5):470-8

______________________________________________________

68Ga-Based Radiopharmaceuticals: Production and Application Relationship

Molecules. 2015 Jul 16;20(7):12913-43

______________________________________________________

(99m) Tc-human serum albumin nanocolloids: particle sizing and radioactivity distribution

J Labelled Comp Radiopharm. 2015 Jul;58(9):376-82

______________________________________________________

Freeware for reporting radiation dosimetry following the administration of radiopharmaceuticals

Appl Radiat Isot. 2015 Sep;103:131-4

______________________________________________________

Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances

Ann ICRP. 2015 Jul;44(2 Suppl):7-321

______________________________________________________

Development of a single vial kit formulation of [99mTc]-labeled doxorubicin for tumor imaging and treatment response assessment-preclinical evaluation and preliminary human results

J Labelled Comp Radiopharm. 2015 May 30;58(6):242-9

______________________________________________________

Recent progress of imaging agents for Parkinson’s disease

Curr Neuropharmacol. 2014 Dec;12(6):551-63

______________________________________________________

GMP-compliant (68)Ga radiolabelling in a conventional small-scale radiopharmacy: a feasible approach for routine clinical use

EJNMMI Res. 2015 Apr 24;5:27

______________________________________________________

Retention of [(18)F]fluoride on reversed phase HPLC columns

J Pharm Biomed Anal. 2015 Jul 10;111:209-14

______________________________________________________

Lutetium-177 therapeutic radiopharmaceuticals: linking chemistry, radiochemistry, and practical applications

Chem Rev. 2015 Apr 22;115(8):2934-74

______________________________________________________

Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors

J Med Chem. 2015 May 14;58(9):3817-29

______________________________________________________

Drug Delivery Systems for Imaging and Therapy of Parkinson’s Disease

Curr Neuropharmacol. 2016 May; 14(4): 376–391.

______________________________________________________

Hydroxypyridinonate complex stability of group (IV) metals and tetravalent f-block elements: the key to the next generation of chelating agents for radiopharmaceuticals

Inorg Chem. 2015 Apr 6;54(7):3462-8

______________________________________________________

Single vial kit formulation of DOTATATE for preparation of (177) Lu-labeled therapeutic radiopharmaceutical at hospital radiopharmacy

J Labelled Comp Radiopharm. 2015 Apr;58(4):166-72

______________________________________________________

Theranostic Radiopharmaceuticals Based on Gold Nanoparticles Labeled with (177)Lu and Conjugated to Peptides

Curr Radiopharm. 2015;8(2):150-9.

______________________________________________________

Chemistry and bifunctional chelating agents for binding (177)Lu

Curr Radiopharm. 2015;8(2):86-94.

______________________________________________________

Alternative chromatographic system for the quality control of lipophilic technetium-99m radiopharmaceuticals such as [99mTc(MIBI)6]+

Braz J Med Biol Res. 2015 Mar 3;0:0.

______________________________________________________

Development of a simple kit-based method for preparation of pharmaceutical-grade ⁶⁸Ga-DOTATOC

Nucl Med Commun. 2015 May;36(5):502-10

______________________________________________________

Blood volume analysis by radioisotopic dilution techniques: State of the art

Appl Radiat Isot. 2015 Feb;96C:71-82. doi: 10.1016/j.apradiso.2014.11.014. Epub 2014 Nov 20.

_______________________________________________________

SPECT radiopharmaceuticals for imaging chronic inflammatory diseases in the last decade

Q J Nucl Med Mol Imaging. 2015 Feb 11. [Epub ahead of print]

_______________________________________________________

Untangling the web of European regulations for the preparation of unlicensed radiopharmaceuticals: a concise overview and practical guidance for a risk-based approach

Nucl Med Commun. 2015 Feb 2. [Epub ahead of print]

_______________________________________________________

Radiopharmaceuticals as probes to characterize tumour tissue

Eur J Nucl Med Mol Imaging. 2015 Feb 3. [Epub ahead of print]

_______________________________________________________

Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database

Ann Pharmacother. 2015 Jan;49(1):39-47. doi: 10.1177/1060028014558153. Epub 2014 Nov 3.
_______________________________________________________

Altered Biodistribution of Radiopharmaceuticals Used in Bone Scintigraphy

Semin Nucl Med. 2015 Jan;45(1):81-96. doi: 10.1053/j.semnuclmed.2014.07.007.

_______________________________________________________

Assessment of technetium-99m succimer residual activity reduction using inert non-reactive syringes

J Nucl Med Technol. 2014 Dec 23. pii: jnmt.114.147983. [Epub ahead of print]

_______________________________________________________

Clinical application of ultrasound for preparation of 99mTc-sestamibi complex

Ann Nucl Med. 2014 Dec 25. [Epub ahead of print]

_______________________________________________________

Radiopharmaceuticals in nuclear medicine: recent developments for SPECT and PET studies

Biomed Res Int. 2014;2014:426892. doi: 10.1155/2014/426892. Epub 2014 Dec 21.

_______________________________________________________

Diversification of 99Mo/99mTc separation: Non-fission reactor production of 99Mo as a strategy for enhancing 99mTc availability

J Nucl Med. 2014 Dec 23. pii: jnumed.114.149609. [Epub ahead of print]

_______________________________________________________

Theranostic nanoparticles

J Nucl Med. 2014 Dec;55(12):1919-22. doi: 10.2967/jnumed.114.146019. Epub 2014 Nov 20.

_______________________________________________________

Radiolabeling in Biology

Cell Biochem Biophys. 2014 Nov 21. [Epub ahead of print]

_______________________________________________________

Radiation dose concerns for the pregnant or lactating patient

Semin Nucl Med. 2014;44(6):479-88. doi: 10.1053/j.semnuclmed.2014.06.003.

_______________________________________________________

Radiation doses for pediatric nuclear medicine studies: comparing the North American consensus guidelines and the pediatric dosage card of the European Association of Nuclear Medicine

Pediatr Radiol. 2014 Nov 1. [Epub ahead of print]

_______________________________________________________

A generator-produced gallium-68 radiopharmaceutical for PET imaging of myocardial perfusion

PLoS One. 2014 Oct 29;9(10):e109361. doi: 10.1371/journal.pone.0109361. eCollection 2014.

_______________________________________________________

Radioactivity decontamination of materials commonly used as surfaces in general-purpose radioisotope laboratories

J Nucl Med Technol. 2014 Dec;42(4):292-5. doi: 10.2967/jnmt.114.144303. Epub 2014 Oct 23.

_______________________________________________________

Absorbed radiation doses to staff after implementation of a radiopharmacy clean room

J Nucl Med Technol. 2014 Dec;42(4):289-91. doi: 10.2967/jnmt.114.143289. Epub 2014 Aug 28.

_______________________________________________________

Particle-Size and Radiochemical Purity Evaluations of Filtered 99mTc-Sulfur Colloid Prepared with Different Heating Times

J Nucl Med Technol. 2014 Dec;42(4):283-8. doi: 10.2967/jnmt.114.145391. Epub 2014 Aug 7.

_______________________________________________________

Samarium-153 EDTMP for metastatic bone pain palliation: The impact of europium impurities

Phys Med. 2014 Nov 13. pii: S1120-1797(14)00622-X. doi: 10.1016/j.ejmp.2014.10.078. [Epub ahead of print]

_______________________________________________________

Limulus Amebocyte Lysate Testing: Adapting It for Determination of Bacterial Endotoxin in 99mTc-Labeled Radiopharmaceuticals at a Hospital Radiopharmacy

J Nucl Med Technol. 2014 Dec;42(4):278-82. doi: 10.2967/jnmt.114.146779. Epub 2014 Nov 13.

_______________________________________________________

Fluorine-18 Radiochemistry, Labeling Strategies and Synthetic Routes

Bioconjug Chem. 2014 Dec 4. [Epub ahead of print]

_______________________________________________________

Medicina nuclear y radiofármacos

Radiologia. 2014 Jun;56S1:29-37. doi: 10.1016/j.rx.2014.07.001. Epub 2014 Oct 7

_______________________________________________________

Adverse Reactions to Radiopharmaceuticals in France: Analysis of the National Pharmacovigilance Database

Ann Pharmacother. 2014 Nov 3. pii: 1060028014558153

_______________________________________________________

Preparation and radiochemical control of 99mTc labeled blood pool agent for in vivo labelling of the red blood cells

Acta Pol Pharm. 2014 Mar-Apr;71(2):245-8

_______________________________________________________

Synthesis and in vitro/in vivo evaluation of novel mono- and trivalent technetium-99m labeled ghrelin peptide complexes as potential diagnostic radiopharmaceuticals

Nucl Med Biol. 2014 Aug 23. pii: S0969-8051(14)00487-9. doi: 10.1016/j.nucmedbio.2014.08.012

_______________________________________________________

EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)

Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2175-85. doi: 10.1007/s00259-014-2866-8.

_______________________________________________________

In vivo studies: comparing the administration via and the impact on the biodistribution of radiopharmaceuticals

Nucl Med Biol. 2014 Oct;41(9):772-4. doi: 10.1016/j.nucmedbio.2014.05.141. Epub 2014 Jun 2

_______________________________________________________

Radiosynthesis and Bioevaluation of [68Ga]-Labeled 5,10,15,20-Tetra(4-methylpyridyl)-porphyrin for Possible Application as a PET Radiotracer for Tumor Imaging.

Mol Imaging Biol. 2014 Jul 19. [Epub ahead of print]

_______________________________________________________

Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals

Eur J Nucl Med Mol Imaging. 2014 Nov;41(11):2005-7. doi: 10.1007/s00259-014-2838-z.

_______________________________________________________

99mTc-labeled vasopressin peptide as a radiopharmaceutical for small-cell lung cancer (SCLC) diagnosis

J Med Chem. 2014 Jul 24;57(14):5986-94. doi: 10.1021/jm500272r. Epub 2014 Jul 8.

_______________________________________________________

PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence

Am J Nucl Med Mol Imaging. 2014 Jun 7;4(4):365-84. eCollection 2014

_______________________________________________________

Radiopharmaceutical stem cell tracking for neurological diseases

Biomed Res Int. 2014;2014:417091. doi: 10.1155/2014/417091. Epub 2014 May 25

_______________________________________________________

Development of 68Ga-labeled fatty acids for their potential use in cardiac metabolic imaging

J Labelled Comp Radiopharm. 2014 Jun 15;57(7):463-9. doi: 10.1002/jlcr.3205

_______________________________________________________

Nuclear imaging to support anti-inflammatory drug discovery and development

Q J Nucl Med Mol Imaging. 2014 May 15. [Epub ahead of print]

_______________________________________________________

Targeting monocytes and macrophages by means of spect and pet

Q J Nucl Med Mol Imaging. 2014 May 21. [Epub ahead of print]

_______________________________________________________

Evaluation of body surface area formulae for scaling GFR of adult renal patients: More between-subjects variability explained by DuBois&DuBois formula

Q J Nucl Med Mol Imaging. 2014 Jun 10. [Epub ahead of print]

_______________________________________________________

New SPECT and PET Radiopharmaceuticals for Imaging Cardiovascular Disease

Biomed Res Int. 2014;2014:942960. Epub 2014 May 11

_______________________________________________________

Synthesis of the first radiolabeled 188Re N-heterocyclic carbene complex and initial studies on its potential use in radiopharmaceutical applications

J Labelled Comp Radiopharm. 2014 May 29. doi: 10.1002/jlcr.3203

_______________________________________________________

Performance of a 62Zn/62Cu microgenerator in kit-based synthesis and delivery of [62Cu]Cu-ETS for PET perfusion imaging

Appl Radiat Isot. 2014 May 22;91C:38-43. doi: 10.1016/j.apradiso.2014.05.006

_______________________________________________________

Synthesis and preliminary evaluation of novel 99mTc-labeled folate derivative via click reaction for SPECT imaging

Appl Radiat Isot. 2014 May 14;91C:24-30. doi: 10.1016/j.apradiso.2014.04.020

_______________________________________________________

Prevalence of Adverse Events to Radiopharmaceuticals from 2007 to 2011

J Nucl Med. 2014 May 29. pii: jnumed.114.138057

_______________________________________________________

A (99m) Tc(CO)3 -labeled benzylguanidine with persistent heart uptake

J Labelled Comp Radiopharm. 2014 May 15;57(5):358-64. doi: 10.1002/jlcr.3188

_______________________________________________________

Alpha-emitter radium-223 in the management of solid tumors: current status and future directions

Am Soc Clin Oncol Educ Book. 2014;34:e132-9. doi: 10.14694/EdBook_AM.2014.34.e132.

_______________________________________________________

The role of preclinical models in radiopharmaceutical therapy

Am Soc Clin Oncol Educ Book. 2014;34:e121-5. doi: 10.14694/EdBook_AM.2014.34.e121.

_______________________________________________________

New rhenium complexes with ciprofloxacin as useful models for understanding the properties of [(99m)Tc]-ciprofloxacin radiopharmaceutical

Bioorg Med Chem. 2014 Jul 1;22(13):3262-9. doi: 10.1016/j.bmc.2014.04.058.

_______________________________________________________

Targeting monocytes and macrophages by means of spect and pet

Q J Nucl Med Mol Imaging. 2014 May 21

_______________________________________________________

Pediatric Nuclear Medicine and Radiation Dose

Semin Nucl Med. 2014 May;44(3):202-209. doi: 10.1053/j.semnuclmed.2014.03.009.

_______________________________________________________

Dosimetry for Radiopharmaceutical Therapy

Semin Nucl Med. 2014 May;44(3):172-178. doi: 10.1053/j.semnuclmed.2014.03.007.

_______________________________________________________

Possibilities of optical imaging of the (99m)Tc-based radiopharmaceuticals

J Biomed Opt. 2014 Apr;19(4):046014. doi: 10.1117/1.JBO.19.4.046014.

_______________________________________________________

Production of iodine-124 and its applications in nuclear medicine

Appl Radiat Isot. 2014 Apr 4;90C:138-148. doi: 10.1016/j.apradiso.2014.03.026

_______________________________________________________

International Guidelines for Pediatric Radiopharmaceutical Administered Activities

J Nucl Med. 2014 Apr 17;55(6):869-870

_______________________________________________________

Implementation of Multi-Curie Production of 99mTc by Conventional Medical Cyclotrons

J Nucl Med. 2014 Apr 10;55(6):1017-1022.

_______________________________________________________

PET tracers in musculoskeletal disease beyond FDG

Semin Musculoskelet Radiol. 2014 Apr;18(2):123-32. doi: 10.1055/s-0034-1371015.

_______________________________________________________

Preparation and evaluation of three mucoadhesive dosage forms using (99m)Tc-Ofloxacin

Appl Radiat Isot. 2014 Jul;89:192-8. doi: 10.1016/j.apradiso.2014.01.031.

_______________________________________________________

In vitro evaluation of tc-99m radiopharmaceuticals for gastric emptying studies

Mol Imaging Radionucl Ther. 2014 Feb;23(1):21-4. doi: 10.4274/Mirt.75047.

_______________________________________________________

Evaluation of the bubble point test of a 0.22-μm membrane filter used for the sterilizing filtration of PET radiopharmaceuticals

Ann Nucl Med. 2014 Mar 8.

_______________________________________________________

Rational development of radiopharmaceuticals for HIV-1

Nucl Med Biol. 2014 Apr;41(4):299-308. doi: 10.1016/j.nucmedbio.2014.01.005.

_______________________________________________________

Radionuclides in nephrourology, Part 2: pitfalls and diagnostic applications

J Nucl Med. 2014 May;55(5):786-98. doi: 10.2967/jnumed.113.133454. Epub 2014 Mar 3.

_______________________________________________________

Radionuclides in nephrourology, part 1: Radiopharmaceuticals, quality control, and quantitative indices

J Nucl Med. 2014 Apr;55(4):608-15. doi: 10.2967/jnumed.113.133447. Epub 2014 Feb 18.

_______________________________________________________

¹⁷⁷Lu-EDTMP for treatment of bone pain in patients with disseminated skeletal metastases

J Nucl Med Technol. 2014 Mar;42(1):55-61. doi: 10.2967/jnmt.113.132266. Epub 2014 Feb 6.

_______________________________________________________

Recent advances in chelator design and labelling methodology for (68) Ga radiopharmaceuticals

J Labelled Comp Radiopharm. 2014 Apr;57(4):239-43. doi: 10.1002/jlcr.3146. Epub 2014 Feb 4.

_______________________________________________________

Evaluation of alternative rapid thin layer chromatography systems for quality control of technetium-99m radiopharmaceuticals

Appl Radiat Isot. 2014 Apr;86:57-62. doi: 10.1016/j.apradiso.2013.12.016. Epub 2014 Jan 8.

_______________________________________________________

Development of a new software for comprehensive management and traceability of hospital radiopharmacies

Comput Methods Programs Biomed. 2013 Oct;112(1):166-72

_______________________________________________________

A portable database of adverse reactions and drug interactions with radiopharmaceuticals

J Nucl Med Technol. 2013 Sep;41(3):212-5

_______________________________________________________

Radioimmunotherapy with 177 Lu-DOTA-Rituximab: Final Results of a Phase I/II Study in 31 Patients with Relapsing Follicular, Mantle Cell, and Other Indolent B-Cell Lymphomas

J Nucl Med. 2013 Jul;54(7):1045-52.

_______________________________________________________

Radio-UHPLC: A tool for rapidly determining the radiochemical purity of technetium-99m radiopharmaceuticals?

Appl Radiat Isot. 2013 Aug;78:72-6

______________________________________________________

99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer

J Nucl Med 2013; 54:1–8

_______________________________________________________

Efficacy Considerations for U.S. Food and Drug Administration Approval of Diagnostic Radiopharmaceuticals

J Nucl Med. 2013; 54:1–6

_______________________________________________________

PET radiopharmaceuticals for probing enzymes in the brain

Am J Nucl Med Mol Imaging 2013;3(3):194-216

_______________________________________________________

Radiofluorination using aluminum-fluoride (Al18F)

EJNMMI Res. 2013 May 8;3(1):36

______________________________________________________

Bone metastases radiopharmaceuticals: an overview

Curr Radiopharm. 2013 Mar;6(1):41-7

______________________________________________________

PET Tracers for Clinical Imaging of Breast Cancer

 J Oncol. 2012;2012:710561

_______________________________________________________

Radiosynthesis and preclinical evaluation of 18F-F13714 as a fluorinated 5-HT1A receptor agonist radioligand for PET neuroimaging

J Nucl Med. 2012 Jun;53(6):969-76

_______________________________________________________

A computer program for calculation of approximate embryo/fetus radiation dose in nuclear medicine applications

Mol Imaging Radionucl Ther. 2012 Apr;21(1):19-22

_______________________________________________________

New PET radiopharmaceuticals beyond FDG for brain tumor imaging

 Q J Nucl Med Mol Imaging. 2012 Apr;56(2):173-90

_______________________________________________________

PET with radiolabeled aminoacid

Q J Nucl Med Mol Imaging. 2012 Apr;56(2):151-62

_______________________________________________________

Alteraciones en la biodistribución de los radiofármacos causadas por interacciones medicamentosas

ALASBIMN Journal 4 de mayo de 2012

_______________________________________________________

99mTc-albumin can replace 125I-albumin to determine plasma volume repeatedly

Scand J Clin Lab Invest. 2012 Oct;72(6):447-51

_______________________________________________________

99mTc-labelled human serum albumin cannot replace 125I-labelled human serum albumin to determine plasma volume in patients with liver disease

Clin Physiol Funct Imaging (2012)

_______________________________________________________

Adverse events in nuclear medicine – cause for concern?

Eur J Nucl Med Mol Imaging (2012) 39:782–785

_______________________________________________________

Estado actual del uso del (18F)fluoruro sódico en la patología ósea

Rev Esp Med Nucl. 2012;31(1):51–57

_______________________________________________________

Giving radioiodine. Think about airport security alarms

Rev Esp Med Nucl Imagen Mol. 2012; 31 (3): 148–150

_______________________________________________________

A Review on Therapeutic Approach of Radiopharmaceutical in Health Care System

International Journal of Pharmaceutical & Biological Archives 2012; 3(3):487-492

_______________________________________________________

Survey of the Performance of Commercial Dose Calibrators for Measurement of 123I Activity

J Nucl Med Technol. 2011 Dec;39(4):302-6.

_______________________________________________________

Experiences with citrate rather than heparin as an anticoagulant for 18F-FDG labeling of leukocytes

J Nucl Med Technol. 2011 Dec;39(4):312-6

_______________________________________________________

Advances in drug design of radiometal-based imaging agents for bone disorders

Int J Mol Imaging. 2011;2011:537687

_______________________________________________________

Pediatric Radiopharmaceutical Doses. New Guidelines

Radiology: Volume 261: Number 2 – November 2011. radiology.rsna.org

_______________________________________________________

Dosis efectivas asociadas a las exploraciones multimodales habituales en medicina nuclear

Rev Esp Med Nucl. 2011;30(5):276–285

_______________________________________________________

How to Search Write Prepare and Publish Scientific Papers in the Biomedical Journals

AIM, 2011; 19(2): 68-79

_______________________________________________________

Información incluida en la ficha técnica de los radiofármacos de uso humano autorizados para comercialización en España

Rev Esp Med Nucl. 2011;30(1):41–46

_______________________________________________________

Radiochemical purity testing of 99mTc-labelled radiopharmaceuticals: how much is enough?

Nuclear Medicine Communications 2011, 32:761–763

_______________________________________________________

Extravasation of a Therapeutic Dose of 131I-Metaiodobenzylguanidine. Prevention, Dosimetry, and Mitigation

J Nucl Med 2011; 52:1418–1422

_______________________________________________________

Pitfalls With Radiopharmaceuticals

Am J Med Sci 2011; 342(1):50–53

_______________________________________________________

Biokinetics and dosimetry of commonly used radiopharmaceuticals in diagnostic nuclear medicine – a review

Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2269-81

_______________________________________________________

Sistema actual de la clasificación de radiofármacos

Rev Esp Med Nucl. 2011; 30 (2): 117–119

_______________________________________________________

99mTc-besilesomab (Scintimun) in peripheral osteomyelitis. Comparison with 99mTc-labelled white blood cells

freeEur J Nucl Med Mol Imaging (2011) 38:899–910

_______________________________________________________

Minimizing and Communicating Radiation Risk in Pediatric Nuclear Medicine

freeJ Nucl Med. 2011 Aug;52(8):1240-51

_______________________________________________________

Development of a Comprehensive Software Application for Calculations in Nuclear Medicine and Radiopharmacy

J Nucl Med Technol. 2010 Sep;38(3):153-62

_______________________________________________________

99Mo 99mTc Generator Shortage Free Web based Software

J Nucl Med • Vol. 51 • No. 8 • August 2010

_______________________________________________________

Altered Biodistribution of Radiopharmaceuticals Role of Radiochemical Pharmaceutical Purity, Physiological, and Pharmacologic Factors

Semin Nucl Med 2010;40:220-241

_______________________________________________________

Aplicación de los factores de ponderación de la Comisión Internacional de Protección Radiológica 103 en el cálculo de la dosis efectiva

Rev Esp Med Nucl. 2010; 29 (3): 114–121

_______________________________________________________

Cyclotron production of 99mTc. An approach to the medical isotope crisis

J Nucl Med. 2010 Apr;51(4):13N-6N

_______________________________________________________

Guidance on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals

Eur J Nucl Med Mol Imaging. 20 March 2010

_______________________________________________________

Imaging of NETs with PET radiopharmaceuticals

Q J Nucl Med Mol Imaging 2010; 54:16-23

_______________________________________________________

Notificación de una reacción adversa al 99mTc-nanocoloide de albúmina

Rev Esp Med Nucl. 2010; 29 (6): 308–309

_______________________________________________________

Radioinmunoterapia con cloruro de itrio-ibritumomab tiuxetan (Zevalin)

Rev EspMedNucl.2010;29(1):50–52

_______________________________________________________

Radiolabeled regulatory peptides for imaging and therapy

Current Opinion in Endocrinology, Diabetes & Obesity 2010, 17:69–76

_______________________________________________________

Radiolabeling optimization and reduced staff radiation exposure for high-dose 90Y-ibritumomab tiuxetan (HD-Zevalin)

Nucl Med Biol. 2010 Jan;37(1):85-93. Epub 2009 Oct 12.

_______________________________________________________

Unconventional Nuclides for Radiopharmaceuticals

Molecular Imaging, Vol 9, No 1 (January/February 2010): pp 1–20

_______________________________________________________

The options for the future production of the medical isotope 99Mo

Eur J Nucl Med Mol Imaging (2010) 37:1817–1820

_______________________________________________________

Guidelines for the labelling of leucocytes with (111)In-oxine. Inflammation/Infection Taskgroup of the European Association of Nuclear Medicin

Eur J Nucl Med Mol Imaging. 2010 April;37(4):835-41

_______________________________________________________

Estimated glomerular filtration rate for drug dose adjustment. Cockcroft and Gault or abbreviated MDRD equation

Clin Biochem. 2009 Jan;42(1-2):111-3. Epub 2008 Oct 9

_______________________________________________________

Guidance for nuclear medicine staff on radiopharmaceuticals drug interaction

Brazilian Journal of  Pharmaceutical Sciences vol. 45, n. 4, oct./dec., 2009

_______________________________________________________

Latest advances in radiopharmacology and radiopharmacy 2009

Q J Nucl Med Imaging 2009;53:357-8

_______________________________________________________

Undesirable Events With Radiopharmaceuticals

Tohoku J. Exp. Med., 2009, 217, 251-257

_______________________________________________________

68Ga-PET a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals

Contrast Media Mol. Imaging 2008, 3 67–77

_______________________________________________________

Adverse Reactions to Radiopharmaceuticals (ARRP) Particularly To Technetium Radiopharmaceuticals

FABAD J. Pharm. Sci., 33, 109–117, 2008

_______________________________________________________

Evaluación de la función ventricular en Medicina Nuclear

Rev Esp Med Nucl. 2008;27(5):374-400

_______________________________________________________

Evaluation of different counting methods for use in radiochemical purity testing procedures for 99mTc-labelled radiopharmaceuticals

Applied Radiation and Isotopes 66 (2008) 556–559

_______________________________________________________

GMP Three letters with many interpretations. Protection of patients or killing the clinical and research applications of PET?

Eur J Nucl Med Mol Imaging (2008) 35:693–694

_______________________________________________________

Radiopharmaceutical Drug Interactions

Rev. salud pública. 10 (3):477-487, 2008

_______________________________________________________

Radiopharmaceuticals drug interactions. A critical review

Anais da Academia Brasileira de Ciências (2008) 80(4): 665-675

_______________________________________________________

The specific case of radiopharmaceuticals and GMP – activities of the Radiopharmacy Committee

Eur J Nucl Med Mol Imaging (2008) 35:1400–1401

_______________________________________________________

Blood Volume Analysis. A New Technique and New Clinical Interest Reinvigorate a Classic Study

J Nucl Med Technol 2007; 35:55–63

_______________________________________________________

Cinética de la estabilidad del radiofármaco 99mTc-DTPA. Influencia de la temperatura

An. R. Acad. Nac. Farm., 2007, 73: 693-701

_______________________________________________________

Comparison of Red Cell and Whole Blood Volume as Performed Using Both Chromium-51-Tagged Red Cells and Iodine-125-Tagged Albumin and Using I-131-Tagged Albumin and Extrapolated Red Cell Volume

Am J Med Sci. 2007 Jul;334(1):37-40.

_______________________________________________________

Development and Prospective Evaluation of an Automated Software System for Quality Control of Quantitative 99mTc-MAG3 Renal Studies

J Nucl Med Technol 2007; 35:27–33

_______________________________________________________

Development of Radioimmunotherapeutic and Diagnostic Antibodies. An Inside-Out View

Nucl Med Biol. 2007 October ; 34(7): 757–778

_______________________________________________________

Impact Factors in Nuclear Medicine Journals

J Nucl Med 2007; 48:1397–1400

_______________________________________________________

Sobre algunos términos de uso frecuente en Medicina Nuclear

Rev Esp Med Nucl. 2007;26(3):173-5

_______________________________________________________

Techniques used for the determination of blood volume

Am J Med Sci. 2007 Jul;334(1):32-6

_______________________________________________________

Ten Simple Rules for Making Good Oral Presentations

PLoS Computational Biology. April 2007  Volume 3  Issue 4  e77

_______________________________________________________

The new EANM paediatric dosage card

Eur J Nucl Med Mol Imaging (2007) 34:796–798

_______________________________________________________

Yttrium-90 Microspheres (TheraSphere and SIR-Spheres) for the Treatment of Unresectable Hepatocellular Carcinoma.

Issues in Emerging Health Technologies Issue 102 • September 2007

_______________________________________________________

Structural overview of technetium compounds (2000–2004)

Coordination Chemistry Reviews 250 (2006) 561–573

_______________________________________________________

Labeling of antibiotics for infection diagnosis

Q J Nucl Med Mol Imaging. 2006 Jun;50(2):147-52

_______________________________________________________

Radioinmunoterapia con 90Y-Ibritumomab Tiuxetan en los linfomas

Rev Esp Med Nucl. 2006;25(1):55-70

_______________________________________________________

Preparation of Tc-99m-macroaggregated albumin from recombinant human albumin for lung perfusion imaging

European Journal of Pharmaceutics and Biopharmaceutics 62 (2006) 26–31

_______________________________________________________

Hepatitis C Virus Infections From a Contaminated Radiopharmaceutical Used in Myocardial Perfusion Studies

JAMA, October 25, 2006—Vol 296, No. 16

_______________________________________________________

A brief history of cell labelling

Q J Nucl Med Mol Imaging 2005;49:304-7

_______________________________________________________

New directions in the coordination chemistry of 99mTc. A reflection on technetium core structures and a strategy for new chelate design

Nuclear Medicine and Biology 32 (2005) 1–20

_______________________________________________________

Nueva formulación para marcar ciprofloxacina con 99mTc

Rev Esp Med Nucl, 2005;24(5):364-5

_______________________________________________________

Optimised tracer-dependent dosage cards to obtain weight-independent effective doses

Eur J Nucl Med Mol Imaging (2005) 32:581–588

_______________________________________________________

Succinylated gelatine. An alternative to hydroxyethyl starch for labelling leukocytes with 99mTc-HMPAO

Nuclear Medicine Communications 2005, 26:749–752

_______________________________________________________

Ten Simple Rules for Getting Published

PLoS Computational Biology. October 2005  Volume 1  Issue 5  e57

_______________________________________________________

Towards a harmonized radiopharmaceutical regulatory framework in Europe

Q J Nucl Med Mol Imaging 2005; 53:394-401

_______________________________________________________

A Better Method of Quality Control for 99mTc-Tetrofosmin

J Nucl Med Technol 2004; 32:72–78

_______________________________________________________

Calidad ¿únicamente una moda?

Rev Esp Med Nucl, 2004;23(4):243-4

_______________________________________________________

Control de calidad de activímetros

Rev Esp Med Nucl, 2004;23(6):434-43

_______________________________________________________

Estabilidad de alimento sólido marcado con diferentes radiofármacos para vaciamiento gástrico

Rev Esp Med Nucl, 2004;23(5):343-6

_______________________________________________________

Estudios isotópicos en nefrourología pediátrica

Rev Esp Med Nucl, 2004;23(1):49-55

_______________________________________________________

Guidelines for the measurement of glomerular filtration rate using plasma sampling

Nuclear Medicine Communications 2004, 25:759–769

_______________________________________________________

Irradiación hepática selectiva con microesferas cargadas con Ytrio90

Oncología, 2004; 27 (4):234-236

_______________________________________________________

Marcación de leucocitos utilizando coloide estannoso-99mTc a partir de muestras de sangre entera

Rev Esp Med Nucl, 2004;23(1):22-6

_______________________________________________________

Medición de la función renal por técnicas de aclaramiento de radionúclidos

Alasbimn Journal 6(23): January 2004. Article N° AJ23-8

_______________________________________________________

Alternative quality control for technetium-99m IDA complexes

Applied radiation and isotopes. 2004;61:1151-55

_______________________________________________________

Sinoviortesis radioisotópica

Rev Esp Med Nucl, 2004;23(1):49-55

_______________________________________________________

A Simple and Effective Technique to Reduce Staff Exposure During the Preparation of Radiopharmaceuticals

J Nucl Med Technol 2003; 31:37–40

_______________________________________________________

Performance of a device to minimise radiation dose to the hands during radioactive syringe calibrations

Eur J Nucl Med Mol Imaging (2003) 30:819-825

_______________________________________________________

Drug Interactions With Radiopharmaceuticals. Effect on the Labeling of Red Blood Cells with Technetium-99m and on the Bioavailability of Radiopharmaceuticals

Brazilian Archives of Biology and Technology. Vol.45, Special n.: pp. 143-149. September 2002

_______________________________________________________

Labeling of Mixed Leukocytes with 99mTc-HMPAO Causes Severe Chromosomal Aberrations in Lymphocytes

J Nucl Med 2002; 43:203-206

______________________________________________________

Método rápido de marcaje de leucocitos con 99mTc HM-PAO

Rev. Esp. Med. Nuclear 21, 5 (343-348), 2002

_______________________________________________________

Radiochemical purity and particles number determinations of modified 99mTc-macroaggregated albumin

J.Serb.Chem.Soc. 67 (8–9) 573–579 (2002)

_______________________________________________________

Synthesis of 99mTc-ciprofloxacin by different methods and its biodistribution

Applied Radiation and Isotopes 57 (2002) 193–200

_______________________________________________________

Effects of methylene blue stabilizer on in vitro viability and chemotaxis of 99mTc-exametazime-labeled leukocytes

J Nucl Med. 2002 Jul;43(7):928-32

_______________________________________________________

Chemotaxis, Viability, and Labeling Stability of Leukocytes Labeled with 99mTc-Exametazime Stabilized with Methylene Blue

J Nucl Med 2001; 42:505-508

_______________________________________________________

99mTc-MAG3. Review of pharmacokinetics, clinical application to renal diseases and quantification of renal function

Annals of Nuclear Medicine Vol. 15, No. 3, 179-190, 2001

_______________________________________________________

A simple and inexpensive preparation of [(51)Cr]-MAA particles

Nucl Med Biol. 2001 Apr;28(3):339-44

_______________________________________________________

Cálculo de las volemias mediante dilución isotópica. Revisión teórica y práctica

Rev. Esp. Med. Nuclear 20, 6 (466-472), 2001

_______________________________________________________

Biodistribution and dosimetry of 99mTc-ciprofloxacin, a promising agent for the diagnosis of bacterial infection

Eur J Nucl Med (2001) 28:570–574

_______________________________________________________

Are Leukocytes Labeled with Stabilized 99mTc-HMPAO Becoming Activated During Labeling?

J Nucl Med. Vol. 42, nº 4, April 2001

_______________________________________________________

Radiofármacos PET

Rev. Esp. Med. Nuclear 20, 6 (477-498), 2001

_______________________________________________________

Self-radioiodination of iodogen

Applied Radiation and Isotopes 54 (2001) 749-752

_______________________________________________________

Structural overview of technetium compounds (1993–1999)

Coordination Chemistry Reviews 214 (2001) 43–90

_______________________________________________________

Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides

Nucl Med Biol. 2001 May;28(4):409-18

_______________________________________________________

Evaluation of an Alternative Radiochemical Purity Testing Method for Technetium-99m-Sestamibi

J Nucl Med Technol 2000; 28:259–263

_______________________________________________________

Marcaje de ceftizoxima con 99mTc

Rev. Esp. Med. Nuclear 19, 7 (479-483), 2000

_______________________________________________________

Measurement of plasma volume using 99Tc(m)-labelled DMP-HSA

Nucl Med Commun. 2000 Jun;21(6):539-44

_______________________________________________________

Performance of a 62Zn-62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM

J Nucl Med. 2000 Feb;41(2):309-14

_______________________________________________________

Should whole-body red cell mass be measured or calculated

Blood Cells Mol Dis. 2000 Feb;26(1):25-31; discussion 32-6.

_______________________________________________________

Simplified algorithms for the estimation of 99Tcm-MAG3 clearance

Nucl Med Commun. 2000 Jan;21(1):65-9

_______________________________________________________

Artefacts in the thin-layer chromatographic analysis of 99Tcm-tetrofosmin injections

Nucl Med Commun. 1999 May;20(5):439-44

_______________________________________________________

Coloides en linfogammagrafía. Aplicación al ganglio centinela

Rev. Esp. Med. Nuclear, 18, 6 (457-464), 1999

_______________________________________________________

Effect of obesity on red cell mass results

fJ Nucl Med. 1999 Mar;40(3):422-8

_______________________________________________________

Effects of alternative reconstitution procedures on the labelling efficiency and in vitro stability of 99Tcm-labelled radiopharmaceuticals

Nucl Med Commun. 1999 Jan;20(1):61-5

_______________________________________________________

Estimating plasma volume from red cell volume

Nucl Med Commun. 1999 Dec;20(12):1165-7

_______________________________________________________

Labelling of platelets with indium-111 oxine and technetium-99m HMPAO: suggested methods

Eur J Nucl Med. 1999;26(12):1614-1616

_______________________________________________________

Un método alternativo para determinar la pureza radioquímica de las preparaciones de 99mTc-Tetrofosmina

Rev. Esp. Med. Nuclear 18, 2 (94-98), 1999

_______________________________________________________

Utilización de un ciclotrón para la producción de radionucleidos emisores de positrones

fRev. Esp. Med. Nuclear, 18, 4 (261-267), 1999

_______________________________________________________

Validación de la preparación de dosis individuales de 51Cr-EDTA en jeringas

Rev. Esp. Med. Nuclear, 18, 4 (272-275), 1999

_______________________________________________________

The influence of stereoisomerism on the pharmacokinetics of Tc radiopharmaceuticals

Q J Nucl Med. 1998 Dec;42(4):280-93

_______________________________________________________

Rapid miniaturized chromatography for technetium-99m-tetrofosmin

J Nucl Med Technol. 1997 Mar;25(1):52-4

_______________________________________________________

Red cell mass and plasma volume measurement

Nucl Med Commun. 1997 Mar;18(3):189-90

_______________________________________________________

Clinical Radiopharmacy. Principles and Practices

Seminars in Nuclear Medicine, Vol XXVI, No 2 (April), 1996: pp 77-84

_______________________________________________________

Measurement of Blood Volume and Red Cell Mass. Re-examination of 51Cr and 125I Methods

Blood Cells Mol Dis. 1996;22(2):169-86

_______________________________________________________

Measurement of Renal Function with Technetium-99m-MAG3 in Children and Adults

J Nucl Med 1996; 37:588-593

_______________________________________________________

MIRDOSE. Personal computer software for internal dose assessment in nuclear medicine

J Nucl Med. 1996 Mar;37(3):538-46

_______________________________________________________

Prevalence of Adverse Reactions in Nuclear Medicine

J Nucl Med 1996; 37:185-192

_______________________________________________________

Problems associated with the clinical use of radiopharmaceuticals. A proposed classification system and troubleshooting guide

Eur J Nucl Med (1996) 23:997-1002

_______________________________________________________

Radiopharmaceutical-Related Pitfalls and Artifacts

Semin Nucl Med. 1996 Oct;26(4):208-55

_______________________________________________________

Report of the Radionuclides in Nephrourology Committee on Renal Clearance

J Nucl Med 1996; 37:1883-1890

_______________________________________________________

Failure to label red blood cells adequately in daily practice using an in vivo method. Methodological and clinical considerations

Eur J Nucl Med. 1995 Jan;22(1):61-7

_______________________________________________________

Quality assurance of radiopharmaceuticals

Nucl Med Commun. 1994 Nov;15(11):886-9

_______________________________________________________

Drug interactions with radiopharmaceuticals

Eur J Nucl Med. 1994;21:348-356

_______________________________________________________

Radioisotopic Labels for Blood cell Survival Studies: a Review

Nucl Med Biol. 1993 Oct;20(7):809-17

_______________________________________________________

An assessment of factors which influence the effectiveness of the modified in vivo technetium-99m-erythrocyte labeling technique in clinical use

J Nucl Med. 1992 Dec;33(12):2222-5

_______________________________________________________

Intrasubject comparison between technetium-99m-ECD and technetium-99m-HMPAO in healthy human subjects

J Nucl Med. 1992 Apr;33(4):480-4

_______________________________________________________

The Technetium-99m-DTPA Renal Uptake Plasma Volume Product. A Quantitative Estimation of Glomerular Filtration Rate

J NucI Med 1992;33:1712-1716

_______________________________________________________

99Tcm-exametazime-labelled leucocytes. Effect of volume and concentration of exametazime on labelling efficiency

Nucl Med Commun. 1991 Aug;12(8):719-23

_______________________________________________________

Estimation of glomerular filtration rate in infants and in children using a single-plasma sample method

J Nucl Med 1991; 32:1294-1297

_______________________________________________________

Reference values for red cell survival times

 J Nucl Med. 1991 Dec;32(12):2245-8

_______________________________________________________

A radiopharmaceuticals schedule for imaging in paediatrics

Eur J Nucl Med (1990) 17:127-129

_______________________________________________________

Radiopharmaceutical factors in the variable quality of [99mTc]HM-PAO images of the brain

J Nucl Med. 1990 Jan;31(1):118-22

_______________________________________________________

Radiopharmaceuticals. State of the art

Eur J Nucl Med. 1990;17(6-8):346-64

_______________________________________________________

The chemistry of 99mTc-labeled radiopharmaceuticals

Semin Nucl Med. 1990 Jan;20(1):5-27

_______________________________________________________

Cationic Complexes of Technetium for Myocardial Imaging

 J Nucl Med 30: 1415-1419, 1989

_______________________________________________________

Estimation of ERPF in adults from plasma clearance of 131I-hippuran using a single injection and one or two blood samples

Int J Rad Appl Instrum B. 1989;16(4):381-3

_______________________________________________________

Estimation of Technetium-99m-MAG3 Plasma Clearance in Adults from One or Two Blood Samples

J Nucl Med 30:1955-1959, 1989

_______________________________________________________

Kinetic Analysis of Technetium-99m d,l-HM-PAO Decomposition in Aqueous Media

J Nucl Med 29:1568-1576, 1988

_______________________________________________________

Recommended Method for Indium-111 Platelet Survival Studies

J Nucl Med 29:564-566,1988

_______________________________________________________

Technetium-99m HM-PAO stereoisomers. Differences in interaction with glutathione

J Nucl Med. 1988 Dec;29(12):1998-2000

_______________________________________________________

Single-sample method for the estimation of glomerular filtration rate in children

J Nucl Med. 1987 Mar;28(3):366-71

_______________________________________________________

Evaluation of mathematic models to assess platelet kinetics

J Nucl Med 27:1192-1201, 1986

_______________________________________________________

Measurement of splenic function with heat-damaged RBCs: effect of heating conditions: concise communication

 J Nucl Med. 1984 Sep;25(9):965-8

_______________________________________________________

Recommended Method for Radioisotope Red Cell Survival Studies

British Journal of Haematology, 1980. 45, 659-666

_______________________________________________________

Recommended methods for measurement of red-cell and plasma volume: International Committee for Standardization in Haematology

J Nucl Med. 1980 Aug;21(8):793-800

_______________________________________________________

Rapid miniaturized chromatographic quality-control procedures for Tc-99m radiopharmaceuticals

J Nucl Med. 1977 Dec;18(12):1230-3

_______________________________________________________

Recommended methods for radioisotope platelet survival studies

Blood. 1977 Dec;50(6):1137-44

_______________________________________________________

Simultaneous red cell mass and plasma volume determinations using 51Cr tagged red cells and 125I labeled albumin

J Nucl Med. 1965, 6:433-440

_______________________________________________________

Anuncios

Responder

Introduce tus datos o haz clic en un icono para iniciar sesión:

Logo de WordPress.com

Estás comentando usando tu cuenta de WordPress.com. Cerrar sesión /  Cambiar )

Google photo

Estás comentando usando tu cuenta de Google. Cerrar sesión /  Cambiar )

Imagen de Twitter

Estás comentando usando tu cuenta de Twitter. Cerrar sesión /  Cambiar )

Foto de Facebook

Estás comentando usando tu cuenta de Facebook. Cerrar sesión /  Cambiar )

Conectando a %s